Bergan Kdv Wealth Management, LLC Exagen Inc. Transaction History
Bergan Kdv Wealth Management, LLC
- $999 Million
- Q2 2023
A detailed history of Bergan Kdv Wealth Management, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 2,500 shares of XGN stock, worth $4,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500Holding current value
$4,550% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
35Shares Held
6.21MCall Options Held
1.6KPut Options Held
4.1K-
Rtw Investments, LP New York, NY1.5MShares$2.74 Million0.04% of portfolio
-
Cowen And Company, LLC899KShares$1.64 Million0.05% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT787KShares$1.43 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY545KShares$991,6760.01% of portfolio
-
Perkins Capital Management Inc494KShares$898,2990.68% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $29.6M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...